Renny Abraham

Introduction

Renny Abraham is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals with a total of two patents to his name. With a focus on innovative compounds that target specific receptors, his work is instrumental in the development of new therapeutic agents.

Latest Patents

Renny's most recent patents include:

1. **Polycyclic Amides as Muscarinic M1 Receptor Positive Allosteric Modulators**: This invention pertains to compounds that act as positive allosteric modulators for the muscarinic M1 receptor. The patent describes the preparation, pharmaceutical compositions, and the application of compounds of formula (I) and their variations, which could lead to advancements in therapies targeting this receptor.

2. **Sulfone Compounds as 5-HT6 Receptor Ligands**: This innovative patent covers novel sulfone compounds that serve as ligands for the 5-HT6 receptor. It includes derivatives, prodrugs, tautomers, and other variations of these compounds, which are anticipated to be beneficial in treating disorders related to 5-HT receptor functions.

Career Highlights

Renny Abraham works for Suven Life Sciences Limited, a company known for its focus on drug discovery and development. His dedication to research and innovation has set the groundwork for future drug development in the pharmaceutical industry.

Collaborations

Throughout his career, Renny has collaborated with esteemed professionals such as Ramakrishna Nirogi and Anil Karbhari Shinde. These partnerships have enhanced the quality and scope of his research efforts, contributing to the advancement of pharmaceutical science.

Conclusion

Renny Abraham stands out as a significant figure in the realm of pharmaceutical innovations. With his patents paving the way for new therapeutic solutions, his work continues to influence the industry positively. His contributions highlight the importance of innovative research in the pursuit of medical advancements.